Malignant peritoneal cytology in endometrial cancer

We read with interest the paper from Matsuo et al. [1] The authors performed a retrospective cohort study on early stage endometrial cancer staging, using data from the Surveillance, Epidemiology, and End Results (SEER) Program, from 2010 to 2016. They observed that malignant peritoneal cytology is associated with worse survival outcomes in women with stage I endometrioid endometrial cancer, and the major impact was observed in intermediate-high risk subgroup [1]. The last 2009 FIGO (International Federation of Obstetrics and Gynecology) staging system revised the previous system (FIGO 1988) modifying the criteria to define stage I, II and III disease [2].

Lascia un commento